Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy.
Minerva Urol Nephrol
; 74(1): 77-84, 2022 02.
Article
em En
| MEDLINE
| ID: mdl-33439572
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Inibidores de 5-alfa Redutase
/
COVID-19
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article